ID

30864

Description

Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00724568

Link

https://clinicaltrials.gov/show/NCT00724568

Keywords

Versions (1)
  1. 6/28/18 6/28/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 28, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT00724568

English

Eligibility Multiple Myeloma NCT00724568

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
you will be eligible to participate in this study if you are at least 18 years old and have newly diagnosed multiple myeloma.
Description

Age | Multiple Myeloma

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0026764
you will have blood tests and other screening tests before you are enrolled and your test results must be within the limits outlined for eligibility to participate in this experimental study.
Description

Hematologic Tests | Screening test | Test Results Within defined limits Study Protocol

Data type

boolean

Alias
UMLS CUI [1]
C0018941
UMLS CUI [2]
C0871311
UMLS CUI [3,1]
C0456984
UMLS CUI [3,2]
C4047968
UMLS CUI [3,3]
C2348563
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
chronic obstructive or chronic restrictive pulmonary disease and cirrhosis.
Description

Chronic Obstructive Airway Disease | Restrictive lung disease chronic | Liver Cirrhosis

Data type

boolean

Alias
UMLS CUI [1]
C0024117
UMLS CUI [2,1]
C0085581
UMLS CUI [2,2]
C0205191
UMLS CUI [3]
C0023890
patient has hypersensitivity to bortezomib, boron or mannitol or any of the components of doxil.
Description

Hypersensitivity Bortezomib | Hypersensitivity Boron | Mannitol allergy | Hypersensitivity Doxil Component

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1176309
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0006030
UMLS CUI [3]
C0571922
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0279284
UMLS CUI [4,3]
C1705248
female subject is pregnant or breast-feeding.
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patient has received other investigational drugs with 14 days before
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
uncontrolled diabetes mellitus.
Description

Diabetic - poor control

Data type

boolean

Alias
UMLS CUI [1]
C0421258
hypersensitivity to acyclovir or similar anti-viral drug.
Description

Aciclovir allergy | Hypersensitivity Antiviral Agents Similar

Data type

boolean

Alias
UMLS CUI [1]
C0571297
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0003451
UMLS CUI [2,3]
C2348205
known hiv infection.
Description

HIV Infection

Data type

boolean

Alias
UMLS CUI [1]
C0019693
known active hepatitis b or c viral infection.
Description

Hepatitis B | Hepatitis C

Data type

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
known intolerance to steroid therapy.
Description

Intolerance Steroid therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0231199
UMLS CUI [1,2]
C0149783
known hypersensitivity to required prophylactic medications.
Description

Hypersensitivity Pharmaceutical Preparations Prophylactic treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0199176
Back to the top of the page

Similar models

Eligibility Multiple Myeloma NCT00724568

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age | Multiple Myeloma
Item
you will be eligible to participate in this study if you are at least 18 years old and have newly diagnosed multiple myeloma.
boolean
C0001779 (UMLS CUI [1])
C0026764 (UMLS CUI [2])
Hematologic Tests | Screening test | Test Results Within defined limits Study Protocol
Item
you will have blood tests and other screening tests before you are enrolled and your test results must be within the limits outlined for eligibility to participate in this experimental study.
boolean
C0018941 (UMLS CUI [1])
C0871311 (UMLS CUI [2])
C0456984 (UMLS CUI [3,1])
C4047968 (UMLS CUI [3,2])
C2348563 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Chronic Obstructive Airway Disease | Restrictive lung disease chronic | Liver Cirrhosis
Item
chronic obstructive or chronic restrictive pulmonary disease and cirrhosis.
boolean
C0024117 (UMLS CUI [1])
C0085581 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0023890 (UMLS CUI [3])
Hypersensitivity Bortezomib | Hypersensitivity Boron | Mannitol allergy | Hypersensitivity Doxil Component
Item
patient has hypersensitivity to bortezomib, boron or mannitol or any of the components of doxil.
boolean
C0020517 (UMLS CUI [1,1])
C1176309 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0006030 (UMLS CUI [2,2])
C0571922 (UMLS CUI [3])
C0020517 (UMLS CUI [4,1])
C0279284 (UMLS CUI [4,2])
C1705248 (UMLS CUI [4,3])
Pregnancy | Breast Feeding
Item
female subject is pregnant or breast-feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Investigational New Drugs
Item
patient has received other investigational drugs with 14 days before
boolean
C0013230 (UMLS CUI [1])
Diabetic - poor control
Item
uncontrolled diabetes mellitus.
boolean
C0421258 (UMLS CUI [1])
Aciclovir allergy | Hypersensitivity Antiviral Agents Similar
Item
hypersensitivity to acyclovir or similar anti-viral drug.
boolean
C0571297 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0003451 (UMLS CUI [2,2])
C2348205 (UMLS CUI [2,3])
HIV Infection
Item
known hiv infection.
boolean
C0019693 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
known active hepatitis b or c viral infection.
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
Intolerance Steroid therapy
Item
known intolerance to steroid therapy.
boolean
C0231199 (UMLS CUI [1,1])
C0149783 (UMLS CUI [1,2])
Hypersensitivity Pharmaceutical Preparations Prophylactic treatment
Item
known hypersensitivity to required prophylactic medications.
boolean
C0020517 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0199176 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial